Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) announced it will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. Eastern time to discuss its second quarter 2026 financial results. Investors can access the call live via webcast on the company’s Investors page or by registering in advance for telephone participation to receive dial-in details, a unique passcode, and registrant ID. A replay of the call will also be available on the Investors page.

News Market Reaction – EBS

-1.06%

-1.06% Session close to close

In the Jul 23 session, EBS declined 1.06%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Prior earnings-date records covered 2 comparable events with an average move of 0.29%, providing mix...

Analysis

Prior earnings-date records covered 2 comparable events with an average move of 0.29%, providing mixed historical context for this scheduling notice. Recent insider activity was Net Selling; the forthcoming results remain the key information to watch.

Key Figures

Results Date: August 5, 2026 Conference Call Time: 5:00 p.m. eastern time

2 metrics

Results Date August 5, 2026 Second-quarter 2026 financial results

Conference Call Time 5:00 p.m. eastern time August 5, 2026 results discussion

Previous Earnings date Reports

2 past events · Latest: Apr 16 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 16	Earnings date	Neutral	+2.2%	Announced first-quarter results date and conference call scheduled for April 30
Feb 12	Earnings date	Neutral	-1.6%	Announced fourth-quarter and full-year results date and conference call

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Comparable earnings-date notices had mixed reactions, ranging from +2.2% to -1.63%, with an average move of 0.29%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the second quarter of 2026.

Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com  

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

FAQ

When will Emergent BioSolutions (EBS) report its Q2 2026 financial results?

Emergent BioSolutions will discuss its Q2 2026 financial results on a conference call on August 5, 2026, at 5:00 p.m. Eastern time. According to Emergent BioSolutions, the call will be accessible via webcast and telephone registration.

How can investors access the Emergent BioSolutions (EBS) Q2 2026 earnings call?

Investors can access the Q2 2026 earnings call via live webcast on the Investors page of Emergent BioSolutions’ website. According to Emergent BioSolutions, telephone participants must register in advance to receive dial-in details and unique access credentials.

What is the time and date of the Emergent BioSolutions (EBS) Q2 2026 conference call?

The Emergent BioSolutions Q2 2026 conference call is scheduled for Wednesday, August 5, 2026, at 5:00 p.m. Eastern time. According to Emergent BioSolutions, the event will cover its financial results for the second quarter of 2026.

How do I register by phone for the Emergent BioSolutions (EBS) Q2 2026 earnings call?

To participate via telephone, investors must register in advance using the provided registration link. According to Emergent BioSolutions, registrants receive a confirmation email with dial-in number, unique passcode, and registrant ID for call access.

Will a replay be available for the Emergent BioSolutions (EBS) Q2 2026 earnings call?

Yes, a replay of the Q2 2026 earnings call will be available on the Investors page of Emergent BioSolutions’ website. According to Emergent BioSolutions, investors can access the replay after the live conference call concludes.

Where can shareholders find the webcast for the Emergent BioSolutions (EBS) Q2 2026 results call?

Shareholders can find the live webcast for the Q2 2026 results call on the Investors page of Emergent BioSolutions’ website. According to Emergent BioSolutions, this page also hosts the replay after the event.